Institutional Ownership
Adc Therapeutics SA
CUSIP H0036K147SHSADCTQ1 2026
13D / 13G Filings
40
Schedule 13D/13G on record
Beneficial Filers
12
Distinct reporting persons
Largest Stake
33.4%
Max % of class reported
Institutional Holders
114
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
40 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Tcg Crossover Gp II, LLC | 13G | 11.0% | 11.39M | SEC |
| 2 | Feb 17, 2026 | Redmile Group, LLC | 13G/A | 12.7% | 15.67M | SEC |
| 3 | Feb 17, 2026 | Orbimed Advisors LLC | 13G/A | 2.6% | 25.92T | SEC |
| 4 | Feb 17, 2026 | Point72 Asset Management, L.P. | 13G/A | 4.0% | 5.01M | SEC |
| 5 | Feb 13, 2026 | Prosight Management, LP | 13G/A | 11.0% | 8.48M | SEC |
| 6 | Nov 13, 2025 | Prosight Management, LP | 13G/A | 11.0% | 7.20M | SEC |
| 7 | Nov 5, 2025 | Oaktree Fund Administration, LLC | 13G/A | 11.0% | 4.67M | SEC |
| 8 | Aug 14, 2025 | Redmile Group, LLC | 13G/A | 14.0% | 15.67M | SEC |
| 9 | Jun 17, 2025 | Point72 Asset Management, L.P. | 13G | 7.0% | 7.83M | SEC |
| 10 | May 19, 2025 | Hpwh Th AG | 13G/A | 9.6% | 9.79M | SEC |
30 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Adc Therapeutics SA.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Redmile Group, LLC | 15.47M | $58.01M |
| 2 | Tcg Crossover Management, LLC | 11.39M | $42.71M |
| 3 | Prosight Management, LP | 8.30M | $31.13M |
| 4 | Blackrock, Inc. | 6.25M | $23.44M |
| 5 | Eventide Asset Management, LLC | 5.70M | $21.38M |
| 6 | Nantahala Capital Management, LLC | 5.60M | $20.99M |
| 7 | Morgan Stanley | 3.81M | $14.30M |
| 8 | Point72 Asset Management, L.P. | 3.38M | $12.68M |
| 9 | Millennium Management LLC | 3.12M | $11.70M |
| 10 | Goldman Sachs Group Inc | 1.65M | $6.20M |